LEXINGTON, Mass.--(BUSINESS WIRE)--Aug. 21, 2006--EPIX Pharmaceuticals (NASDAQ: EPIXD) announced that chief executive officer Michael G. Kauffman, M.D., Ph.D. and other members of management are scheduled to commemorate the company’s recent merger with Predix Pharmaceuticals by ringing the NASDAQ Stock Market closing bell on Tuesday, August 22, 2006 at 4:00 p.m. ET in New York City.
